Page last updated: 2024-09-04

docetaxel anhydrous and Fecal Impaction

docetaxel anhydrous has been researched along with Fecal Impaction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chow, A; Emmenegger, U; Francia, G; Kerbel, RS; Man, S; Wong, A	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Fecal Impaction

Article	Year
Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy. Investigational new drugs, 2014, Volume: 32, Issue:1 Topics: Administration, Metronomic; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fecal Impaction; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Male; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Taxoids; Topotecan; Up-Regulation; Xenograft Model Antitumor Assays	2014

Article

Year

Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.

Investigational new drugs, 2014, Volume: 32, Issue:1

Topics: Administration, Metronomic; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fecal Impaction; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Male; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Taxoids; Topotecan; Up-Regulation; Xenograft Model Antitumor Assays

2014